Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.00
Bid: 102.00
Ask: 106.00
Change: -1.50 (-1.42%)
Spread: 4.00 (3.922%)
Open: 105.50
High: 105.50
Low: 104.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Shareholding

29 Jun 2018 16:59

RNS Number : 1434T
Intercede Group PLC
29 June 2018
 

 

 

 

29 June 2018

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

Director/PDMR shareholdings

 

 

Intercede, the software and service company specialising in identity, credential management and secure mobility, was notified on 29 June 2018 of the following transactions in its ordinary shares of 1 pence ("Ordinary Shares"): 

 

- on 28 June 2018, Richard Parris, Non-Executive Director of the Company, transferred, via sale and purchase, 68,000 Ordinary Shares. He sold 68,000 Ordinary Shares at a price of 29 pence per Ordinary Share from an account in his own name and bought 68,000 Ordinary Shares at a price of 29.02 pence per Ordinary Share to be held in his ISA;

 

- on 28 June 2018, Jayne Murphy, a person closely associated ("PCA") with Richard Parris, Non-Executive Director of the Company, transferred, via sale and purchase, 68,000 Ordinary Shares. She sold 68,000 Ordinary Shares at a price of 29 pence per Ordinary Share from an account in her own name and bought 68,000 Ordinary Shares at a price of 29.02 pence per Ordinary Share to be held in her ISA; and

 

- on 28 June 2018, Jayne Murphy, a ("PCA") with Richard Parris, Non-Executive Director of the Company, sold 10,000 Ordinary Shares at a price of 29 pence per Ordinary Share.

 

- Following these transactions, Richard Parris and PCA's with him are beneficially interested in 5,703,552 Ordinary Shares, representing 11.3% of the Company's issued share capital.

 

ENQUIRIES

 

Intercede Group plc Tel. +44 (0)1455 558 111

Klaas van der Leest, Chief Executive

Andrew Walker, Finance Director

 

finnCap Tel. +44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Simon Hicks, Corporate Finance

 

 

About Intercede

 

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

 

For more information visit: www.intercede.com

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Parris - Non-Executive Director

Jayne Murphy - PCA of Richard Parris

2.

Reason for the Notification

a)

Position/status

See 1(a) above

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Intercede Group plc

b)

LEI

213800VFMNCYCDQ65C90

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence

Identification code

GB0003287249

b)

Nature of the transactions

1. Richard Parris - transfer via sale of 68,000 ordinary shares at 29p per ordinary share and purchase of 68,000 ordinary shares at 29.02p per ordinary share from Mr Parris's own name to his ISA

 

2. Jayne Murphy - transfer via sale of 68,000 ordinary shares at 29p per ordinary share and purchase of 68,000 ordinary shares at 29.02p per ordinary share from Mrs Murphy's own name to her ISA

 

3. Jayne Murphy - sale of ordinary shares

c)

Price(s) and volume(s)

1. Richard Parris

Price(s)

Volume(s)

Sold

29p

 

Bought:

29.02p

 

68,000

 

 

68,000

 

2. Jayne Murphy

Price(s)

Volume(s)

Sold

29p

 

Bought:

29.02p

 

68,000

 

 

68,000

 

3. Jayne Murphy

Price(s)

Volume(s)

Sold

29p

 

10,000

d)

Aggregated information:

· Aggregated volumes

· Prices

See 4(c) above

e)

Date of the transactions

28 June 2018

f)

Place of the transactions

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKMGZVKLMGRZM
Date   Source Headline
10th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSBoard Changes
8th Jun 20227:00 amRNSFinal Results
25th May 202210:15 amRNSInvestor Presentation
12th Apr 20227:00 amRNSAppointment of CFO
6th Apr 20227:00 amRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSTrading Update & Contract Win
30th Mar 202210:01 amRNSReceipt of $3.4m Order
2nd Feb 20227:00 amRNSContract Win
8th Dec 20213:55 pmRNSDirector/PDMR Shareholding and Issue of Equity
23rd Nov 20217:00 amRNSHalf-year Report
19th Nov 20217:00 amRNSHolding(s) in Company-Amendment
17th Nov 20217:00 amRNSInvestor Presentation
16th Nov 20217:00 amRNSHolding(s) in Company
15th Nov 20213:45 pmRNSTotal Voting Rights
11th Nov 20214:12 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSTrading Update
15th Sep 20212:09 pmRNSResult of AGM
15th Sep 20217:00 amRNSMultiple Customers choose to Upgrade MyID
20th Jul 20217:00 amRNSIntercede achieves FIDO2 certification
5th Jul 20217:00 amRNSConnect Partner Programme & Q1 Contract Wins
15th Jun 20218:26 amRNSIssue of Equity
8th Jun 20217:00 amRNSFinal Results
2nd Jun 202110:09 amRNSInvestor Presentation
10th May 20217:00 amRNSShare Incentive Plan
7th Apr 20217:00 amRNSTrading Update & Appointment of Auditor
1st Apr 202110:30 amRNSReceipt of $3.4m Order
10th Mar 20217:00 amRNSShare Incentive Plan
23rd Feb 20217:00 amRNSAmendment to LTIP
22nd Feb 20214:10 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSCLN Conversion to Equity
12th Feb 20217:00 amRNSHolding(s) in Company
8th Feb 202112:40 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSCLN Call & Issue of Equity
11th Jan 20217:00 amRNSNew Contract Win
5th Jan 202111:00 amRNSCLN Conversion to Equity
4th Jan 202110:40 amRNSHolding(s) in Company
22nd Dec 20207:00 amRNSNew Contract Win
24th Nov 20207:00 amRNSHalf-year Report
17th Nov 20207:00 amRNSContract Win: Follow-on Purchase Order
12th Nov 20207:00 amRNSInvestor Presentation
8th Oct 20207:01 amRNSIntercede join the FIDO Alliance
8th Oct 20207:00 amRNSTrading Update
16th Sep 20203:40 pmRNSResult of AGM
20th Aug 20207:05 amRNSContract Win - Initial Progress Order
5th Aug 20202:01 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSContract Win
2nd Jun 20207:00 amRNSFinal Results
12th May 20207:00 amRNSShare Incentive Plan
20th Apr 202010:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.